| PERIOD ENDING | 24-Apr-09 | 23-Jan-09 | 24-Oct-08 | 25-Jul-08 | | Total Revenue | 879,643 | 746,343 | 911,631 | 868,776 | | Cost of Revenue | 345,748 | 353,127 | 365,475 | 352,128 | | | Gross Profit | 533,895 | 393,216 | 546,156 | 516,648 | | | Operating Expenses | | Research Development | 124,986 | 122,661 | 125,496 | 125,352 | | Selling General and Administrative | 339,530 | 342,683 | 355,055 | 352,571 | | Non Recurring | 35,451 | 18,955 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 33,928 | (91,083) | 65,605 | 38,725 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,268 | 9,859 | (5,474) | 10,866 | | Earnings Before Interest And Taxes | 43,196 | (81,224) | 60,131 | 49,591 | | Interest Expense | 7,510 | 7,238 | 7,542 | 4,575 | | Income Before Tax | 35,686 | (88,462) | 52,589 | 45,016 | | Income Tax Expense | (39,398) | (13,070) | 3,408 | 7,344 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 75,084 | (75,392) | 49,181 | 37,672 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 75,084 | (75,392) | 49,181 | 37,672 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $75,084 | ($75,392) | $49,181 | $37,672 |
|
0.45% Nasdaq 
0.20%
Income Statement
